CLINICAL_TRIALS
trial_result
· 2026-02-06
Clinical Trial Update: Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC) [Phase 2]
Summary
A completed Phase 2 trial (DAPAVASC) assesses the vascular effects of dapagliflozin in patients with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Rouen | Conditions: Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED